Epidemiological and Genomic Characteristics of the Widely Disseminated C. difficile Strain, REA Group Y

广泛传播的艰难梭菌菌株 REA Y 组的流行病学和基因组特征

基本信息

  • 批准号:
    10480500
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-10-01 至 2027-09-30
  • 项目状态:
    未结题

项目摘要

Clostridioides difficile is a gram-positive, spore forming, anaerobic bacteria that is the cause of the most common healthcare associated infection. C. difficile infections (CDI) are estimated to cause nearly 450,000 infections and 30,000 deaths within the United States per year. Since the early 2000s, the epidemic strain identified as restriction endonuclease analysis (REA) group BI, PCR ribotype (RT) 027 (BI/RT027) has been the most common cause of CDI in the United States. However, in the past 10 years there has been a drastic change in the molecular epidemiology of C. difficile as BI/RT027 prevalence has decreased. Furthermore, there is evidence that healthcare-associated CDI (HA-CDI) is on the decline and community-associated CDI (CA-CDI) is increasing. One strain identified as REA group Y, which commonly correlates to RT 014 and 020 [Y(RT014/020)], has been endemic in the United States accounting for >5% of all CDI since the 1980s. As BI/RT027 associated CDI has decreased over the past 10 years, Y(RT014/020) related CDI have steadily increased and now account for 10-15% of all CDI. With the rise in CA-CDI, there is rising evidence that Y(RT014/020) resides within an unknown community reservoir. Despite a decades long prevalence and increasing concern with CA-CDI, a detailed molecular analysis of Y(RT014/020) has never been completed. Therefore, our proposal will be to complete a detailed molecular and clinical analysis in conjunction with a rigorous genomic analysis of Y(RT014/020) and BI/RT027 to assess the factors which contribute towards our overarching hypothesis that Y(RT014/020) resides within an unknown community reservoir. Support from the career development award (CDA) will provide Dr. Skinner with the necessary foundation and training to establish himself as a successful VA biomedical and laboratory clinician-scientist focused on the pathogenesis and epidemiology of C. difficile. The molecular epidemiology of C. difficile has continually shifted over multiple decades. These shifts are the results of underlying pathologic factors which influence strain selection. This innovative project will utilize C. difficile from multiple decades to understand the factors which have allowed for one strain (REA group Y) to remain endemic for decades. This information could be further utilized to understand which factors (i.e., antibiotic exposure) place Veterans at risk for developing a CDI and provide a deeper understanding into the mechanisms by which C. difficile is resistant to particular antibiotics. Therefore, the completion of this CDA will provide a critical foundation for Dr. Skinner and results from this project will be used to support Dr. Skinner's VA Merit Review application to study the mechanism by which C. difficile is resistant to certain cephalosporin antimicrobials.
艰难梭菌是革兰氏阳性,孢子形成,厌氧细菌,是最常见的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Michael Skinner其他文献

Andrew Michael Skinner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了